Family Room Entertmt (FMYR) 0.0010 $FMYR Family Room

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Family Room Entertmt (FMYR) 0.0010 $FMYR

Family Room Entertainment Corp. Acquires Film and Sequel/Remake Rights to thriller starring William Shatner by Igo Kantor "Kingdom of the Spiders"
GlobeNewswire - Tue Apr 12, 8:00AM CDT
Family Room Entertainment Corp. (OTC Markets:FMYR), has secured certain distribution and production, co- production and media entertainment rights of the iconic Motion Picture "Kingdom of the Spiders". This applies to both original and all futures rights.

Family Room Entertainment Corp. Offers Film Restoration Services
GlobeNewswire - Mon Sep 28, 10:00PM CDT
Family Room Entertainment Corp. (Pink Sheets:FMYR), Family Room Entertainment Corp understands the VALUE of archive film and tape. With this knowledge we now offer a service that allows us to take any known video tape format recorded in any known TV system from the 60's to the present day and deal precisely with the technical and storage issues that damaged footage presents. If your project is film based we can organize digital scanning of the negative or positive to a file and tape based format for the digital restoration process. Using real time technology in 4:4:4 mode and color grading with real time capture & processing will give us a no-compromise solution to damaged footage and valuable archives.

SHAREHOLDER ALERT: Due Diligence Report on Family Room Entertainment
ACCESSWIRE - Mon Sep 14, 7:36AM CDT
NEW YORK, NY / ACCESSWIRE / September 14, 2015 / Family Room Entertainment Corp. (PINKSHEETS: FMYR) traded 9,295,598 shares on Friday but has a 30 day volume average of 321,968 shares traded daily. Shares closed at $.62, up $.02 per share. FMYR has a history of being a very thinly traded stock.

Family Room Entertainment Corp. to Produce "Slips" Television Show
GlobeNewswire - Thu Sep 03, 1:31PM CDT
Family Room Entertainment Corp. (Pink Sheets:FMYR), announces it will enter into a new venture with Double Decker Media Limited, of London, UK http://www.doubledeckermedia.com. Under the terms of the agreement Family Room will co-produce a television reality show called "Slips" on which Double Decker Media Limited has signed Heads of Terms with the Show's rights owners, where two drivers race each other for the "pink slips" of the loser's car. The show will take place across North America with different venues and locations and vehicles from supercars to muscle cars.

Family Room Entertainment Corp. Forms Venture With Double Decker Media of the UK
GlobeNewswire - Mon Aug 24, 8:00AM CDT
Family Room Entertainment Corp. (Pink Sheets:FMYR), announces a new venture with Double Decker Media Limited, of London, UK http://www.doubledeckermedia.com. Under the terms of the agreement Qin Media, a wholly owned subsidiary of Family Room, will own fifty percent of Double Decker Media Limited. This will create a UK Production Office for Family Room Entertainment Corp. The venture creates access into the UK film market and pipelines of projects from current producers, access to additional funding avenues and will provide UK production capabilities.

Family Room Entertainment Corp. Updates Its Corporate Roster and Board of Directors
GlobeNewswire - Tue Aug 11, 3:32PM CDT
Family Room Entertainment Corp. (Pink Sheets:FMYR), confirms that Stanley Tepper as of 3/15/2015 has continued his involvement as its COO, CFO and Corporate Secretary. Mr. Tepper is also a Director of the company.

Family Room Entertainment Corp. Acquires Qin Media Limited
GlobeNewswire - Thu Apr 09, 6:03PM CDT
Family Room Entertainment Corp. (Pink Sheets:FMYR), announces the appointment of J. R. Wall as Director, CEO and President in conjunction with the acquisition of UK based Qin Media Limited.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading